Showing results (151-160 of 1,181) with videos related to
Sort By:
Pageof 119
Arquivos De Neuro-Psiquiatria|May 4, 2004
[Analysis of methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder]Enio Roberto de Andrade, Claudia ScheuerAnticancer Research|July 5, 2018
Unilateral Creeping Destruction of Deformed Mandibular Ramus and Angle Associated with Extensive Facial Plexiform Neurofibroma in Neurofibromatosis Type 1: A Case Report with Analysis of the Literature for Diagnosing Osteolytic Events of the Mandible in Tumor-suppressor Gene SyndromeReinhard E Friedrich, Hanna A ScheuerJournal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|January 9, 1999
Cross-country digital EEG survey 1998R P Brenner, M L ScheuerMabs|September 24, 2016
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleMichael Dobosz, Ute Haupt, Werner ScheuerAmerican Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 17, 2002
Glucocorticoids modulate baroreflex control of heart rate in conscious normotensive ratsDeborah A Scheuer, Andrea G BechtoldAmerican Journal of Physiology. Heart and Circulatory Physiology|January 18, 2003
Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitariusSylvan S Shank, Deborah A ScheuerJournal of Biomolecular Structure & Dynamics|March 20, 2003
Comparative analysis of docking motifs in MAP-kinases and nuclear receptorsElke Burgermeister, Martin Lanzendoerfer, Werner ScheuerJournal of Natural Products|November 15, 2000
Malyngamides O and P from the sea hare Stylocheilus longicaudaW A Gallimore, P J ScheuerPraxis|June 22, 2005
[The online-consultation of the University Hospital Zurich]R P Neuhaus Bühler, E ScheuerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Combination treatment with erlotinib and pertuzumab against human tumor xenografts is superior to monotherapyThomas Friess, Werner Scheuer, Max HasmannPageof 119